Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/16446328

J. Clin. Oncol. 2006 Feb 1 24 4 563-70

Download in:

View as

General Info

PMID
16446328